Clinical trial
Atomoxetine for Treating Attention Deficit Hyperactivity Disorder in Young…
NCT00254462 · University of Nebraska, Other · Completed
Key facts
| NCT number | NCT00254462 |
|---|---|
| Title | Atomoxetine for Treating Attention Deficit Hyperactivity Disorder in Young Children |
| Official title | Pharmacological Treatment of ADHD in Young Children |
| Lead sponsor | University of Nebraska, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Attention Deficit Disorder With Hyperactivity |
| Intervention type | Behavioral, Drug |
| Interventions | Atomoxetine, Placebo, Parent Training |
| Enrollment | 93 |
| Start date | Oct 1, 2005 |
| Primary completion | Aug 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Nov 16, 2005 |
| Last update posted | Oct 2, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: